President’s Corner Update: Stronger Support in D.C. for Patent Protection

RETWritten By:
Sara Radcliffe
President & CEO
CLSA – California Life Sciences Association 

August 12, 2015

Welcome to our first edition of the CLSA Bulletin! This new monthly publication from the California Life Sciences Association will feature a robust blend of news regarding our federal, state and local advocacy efforts, group purchasing and benefits, the latest happenings at the California Life Sciences Institute (CLSI), upcoming events, partner programs and more.

Since the launch of CLSA nearly three months ago, our team has been hard at work. Our top priority is to create one strong, unified voice for California’s life sciences sector, in order to drive transformative innovations that will benefit patients and consumers in the U.S. and around the world for decades to come.

Congress may be in recess, but the patent debate continues to heat up. Our Washington, D.C. team remains heavily engaged with the California congressional delegation to protect patent rights and oppose misguided legislation that would threaten the ability of life sciences innovators to enforce their intellectual property. Our hard work is paying off. We’re beginning to see a shift in the debate towards a deeper appreciation across our delegation on the importance of patent enforcement rights and protections, and the need to correct flaws in the U.S. Patent and Trademark Office’s (PTO) post grant review processes. Patents are critical to promoting life sciences research, investment and innovation and CLSA is at the forefront of this critical legislative debate. To learn more, check out my recent op-ed published in The Sacramento Bee.

In Sacramento, we’re taking aggressive steps to educate key legislators on the value of biomedical innovation. Our goal is to better communicate the value that new medicines and technologies bring to patients, our healthcare system and the economy. CLSA is engaging directly with patient groups, providers and other stakeholders to recapture the narrative. Click here to view our latest infographics and click here to view my op-ed on the value of medical innovation published in The Sacramento Bee.

I’m pleased to report that our non-profit partner, the California Life Sciences Institute (CLSI), successfully launched in June. Focused on fostering the ecosystem that has made California the world leader in life sciences innovation, CLSI was part of a recently awarded $6 million California Career Pathways Trust grant, which will bring local students together with life sciences and IT companies to assist with developing careers in both sectors. Click here to learn more.

I hope you enjoy this inaugural edition of the CLSA Bulletin and continue to be a part of the CLSA community. Be sure to stay connected with us at, and follow us: @CALifeSciences, Facebook, Instagram, LinkedIn and YouTube.

Best regards,

Sara Radcliffe
President & CEO
California Life Sciences Association